Metabolism of Sulfidopeptide Leukotrienes
Until recently there has been very little known about the ultimate metabolitc fate of the sulfidopeptide leukotrienes. A basic principle of the pharmacology of mediator substances requires that mechanisms exist for biological inactivation of these very potent molecules. One such mechanism might be simple uptake of leukotrienes by the cells which make or respond to them. Studies showing that LTC4, produced in the isolated perfused lung in response to the calcium ionophore A23187, was largely retained by the lung over a span of 10 minutes, and that very little conversion to LTD4/LTE4 took place, suggesting the possibility that a reuptake mechanism for LTC4 in the lung existed (1). Other eicosanoids (LTB4, 6-keto-PGF1, thromboxane B2 and PGE2) were largely released into the perfusate. It is also possible that LTC4 was retained through binding to tissue proteins with high affinity and not taken up into cells. Since direct experiments have now shown that leukotrienes are not stored in cells from which they are released, and, while the retention of LTC4 by the isolated perfused rat lung has not been fully explained, simple reuptake of LTC4 in the lung seems unlikely. At present it is thought that metabolic biotransformation is the primary mechanism of inactivation of the leukotrienes.
KeywordsEnterohepatic Circulation Polar Metabolite Calcium Ionophore A23187 Intraduodenal Administration Metabolic Biotransformation
Unable to display preview. Download preview PDF.
- 1.J.Y. Westcott, T.J. McDonnell, P. Bostwick, and N.F. Voelkel, Eicosanoid production in isolated perfused lungs stimulated with calcium ionophore A23187. Am. Rev. Respir. Dis.,in press.Google Scholar
- 5.E.J. Goetzl, 1982, The conversion of leukotriene C4 to isomers of leukotriene B4 by human eosinophil peroxidase. Biochem. Biophys. Res. Commun., 106:2’70.Google Scholar
- 12.M.C. Ramano, R.D. Eckardt, P.E. Bender, T.B. Leonard, K.M. Straub, and J.F. Newton, 1987, Biochemical characterization of hepatic microsomal leukotriene B4 hydroxylases. J. Biol. Chem., 262: 1590.Google Scholar
- 22.R.C. Murphy, R. Mathews, and W. Pickett, W., Leukotrienes and thromboxanes: Metabolites of essential fatty acids with significant untoward pharmacological properties, in: “Nutritional Factors: Modulating Effects of Metabolic Processes,” E.G. Bassett, ed., Raven Press, N.Y. (1981).Google Scholar
- 24.J. Caldwell, Conjugation reactions of nitrogen centers, in: “Metabolic Basis of Detoxication,” W.B. Jakoby, J.R. Bend, and J. Caldwell, eds., Academic Press, New York (1982).Google Scholar
- 28.J.Y. Westcott, T.J. McDonnel, and N.F. Voelkel, 1988, Alveolar transfer and metabolism of eicosaniods in the ratGoogle Scholar
- 30.L. Orning, L. Kaijser, and S. leukotriene C4 in maw Urinary Res. Commun.,130:214.Google Scholar
- 31.S.R. Wagle and W.R. Ingebretsen, Isolation, purification, and metabolic characteristics of rat liver hepatocytes, in: “Methods in Enzymology,” J.M. Lowenstein, ed., Academic Press, New York (1975).Google Scholar
- 34.H.P. Koch, 1949, Absorption spectra and structure of organic sulfur compounds. Part I. Unsaturated sulphides. J. Chem. Soc., 387.Google Scholar
- 36.C.-H. Chu, L. Kushner, D. Cuebas, and H. Schulz, 1984, The activity of 3hydroxyacyl-CoA epemerase is insufficient to account for the rate of linoleate oxidation in rat heart mitochondria. Evidence for a modified pathway of linoleate degradation. Biochem. Biophys. Res. Commun., 118: 162.PubMedCrossRefGoogle Scholar
- 37.J.A. Zirrolli, A. Fradin, J. Maclouf, and R.C. Murphy, 1988, Analysis of LTB4 and 20-hydroxy-LTB4 in whole blood challenged with zymosan. Proc. Ann. Conf. Mass Spectrom. 36:, in press.Google Scholar
- 39.P. Perrin, J. Zirrolli, D. Stene, J.P. Lellouche, J.P. Beaucourt, and R.C. Murphy, In vivo formation of fl-oxidized metabolites of leukotriene E4 in the rat. Prostaglandins,submitted.Google Scholar